Pregled bibliografske jedinice broj: 1248773
Extracorporeal membrane oxygenation for the treatment of ARDS in Covid-19 and influenza patients: Does etiology matter?
Extracorporeal membrane oxygenation for the treatment of ARDS in Covid-19 and influenza patients: Does etiology matter? // The international journal of artificial organs, 45 (2022), 7; 647-651 doi:10.1177/03913988221092041 (međunarodna recenzija, kratko priopcenje, znanstveni)
CROSBI ID: 1248773 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Extracorporeal membrane oxygenation for the
treatment of ARDS in Covid-19 and influenza
patients: Does etiology matter?
Autori
Kotarski, Viktor ; Santini, Marija ; Krajinović, Vladimir ; Papić, Neven ; Gjurašin, Branimir ; Krznarić, Juraj ; Kutleša, Marko
Izvornik
The international journal of artificial organs (0391-3988) 45
(2022), 7;
647-651
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni
Ključne riječi
ARDS ; COVID 19 ; ECMO ; influenza
Sažetak
At the beginning of the COVID 19 pandemic, the outcome of patients treated with ECMO was discouraging. Subsequently, it became clear that a certain group of patients may benefit from ECMO treatment. The primary objective of this study was to compare the outcome of ECMO treatment in COVID- 19 and influenza patients referred to a tertiary care center. A total of 119 adult patients required ECMO treatment following ARDS secondary to H1N1 (49) and SARS-CoV-2 (70) in the referral ECMO Center based in Zagreb between October 2009 and October 2021. Our study revealed a significantly higher mortality in COVID-19 patients compared to H1N1 influenza when the onset of ARDS was severe enough to require ECMO support. Based on these results and current knowledge, we argue that ECMO treatment for ARDS in COVID-19 patients is more challenging compared to H1N1 influenza patients. Therefore, referral to the most experienced ECMO centers should be considered. Additionally, patient selection and timing for ECMO treatment play a key role in relation to outcome. Mortality rate in COVID-19 patients requiring ECMO treatment may be used as a reference frame for ECMO centers to ensure best possible care and outcome.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Marko Kutleša
(autor)
Vladimir Krajinović
(autor)
Neven Papić
(autor)
Branimir Gjurašin
(autor)
Marija Santini
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE